Results for: Insulin Pen
Find the latest Insulin Pen tenders from different organizations. SigmaTenders helps you participate in these online e-Procurement tenders. We provide access to tender details, BOQs, and technical bids, along with bidding support for Insulin Pen e-tenders. Stay informed with daily email alerts and comprehensive coverage across government websites, GeM, and e-Procurement portals.
Insulin degludec and aspart 100 iu/ml-3 ml (flex touch pen)
For complete deion and other details, please refer to tender
Insulin glargine recombinant dna origin 450 iu/1.5 ml pfs disposable pen
For complete deion and other details, please refer to tender
๐ Urgent Tender for Insulin Glargine Recombinant DNA Origin ๐ The Ministry of Railways, under the Central Government, has issued a tender for the supply of Insulin Glargine Recombinant DNA Origin, with a strength of 450 IU/1.5 ML in a Pre-Filled Syringe (PFS) with a Disposable Pen. ๐ ๐ Bid Submission Deadline: April 18, 2024, 11:30 AM Interested pharmaceutical suppliers are requested to submit detailed bids, including all necessary documentation and compliance with tender specifications, by the stipulated deadline. Keywords: Insulin Glargine, Recombinant DNA, Ministry of Railways, Tender, Pharmaceutical Supplies, Disposable Pen, Pre-Filled Syringe
Insulin degludec 2.56mg aspart 1.05mg in 100iu/ml in pen, brand- ryzodeg
For complete deion and other details, please refer to tender
Insulin aspart penfils (one pen and 50 needle free with 50 cartridge)
For complete deion and other details, please refer to tender
Inj. insulin degludec with insulin aspart {each inj. contains- monocomponent biosynthetic r -dna insulin for in 100 iu/ml cartridge 70 percent insulin degludec (2.56 mg/1ml) with 30 percent insulin aspart (1.05mg/1ml) per 3ml pre filled pen note- five needle suitable for the use of the every five pre filled pen}
For complete deion and other details, please refer to tender
Inj. insulin degludec with insulin aspart, each inj. contains- monocomponent biosynthetic r -dna insulin for in 100 iu/ml cartridge 70 percent insulin degludec (2.56 mg/1ml) with 30 percent insulin aspart (1.05mg/1ml) per 3ml pre filled pen. note- five needle suitable for the use of the every five pre filled pen.
For complete deion and other details, please refer to tender
Inj. insulin degludec with insulin aspart. each inj. contains- monocomponent biosynthetic r dna insulin for in 100 iu/ml cartridge 70 percent insulin degludec (2.56 mg/1ml)with 30 percent insulin aspart (1.05mg/1ml) per 3ml pre filled pen note-five needle suitable for the use of the every five pre filled pen.
For complete deion and other details, please refer to tender
Cartidge insulin mixtard analogue (25/75) {h inj. contains- mixture of lispro insulin 25 percent and lispro protatamine insulin 75 percent ,packed as 3 ml pre filled pen note-ten needle supply with every 50 pre filled pen }
For complete deion and other details, please refer to tender
Cartridge insulin mixtard analogue (25/75) [each inj. contains- mixture of lispro insulin 25 percent and lispro protatamine insulin 75 percent ,packed as 3 ml pre filled pen] note-ten needle supply with every 50 pre filled pen
For complete deion and other details, please refer to tender
Insulin lispro biphasic containing 25 percent insulin lispro & 75 percent insulin lispro protamine suspension (r-dna origin) 3 ml cartridge (01 pen 20 needles free per 20 cartridges)
For complete deion and other details, please refer to tender
Need support responding to this opportunity?
Get matched through GetSaarthi for documentation, proposal preparation, compliance readiness, and execution support.
Get Opportunity Matching Supportof your Industry type